PRR5 Antikörper (AA 51-150) (Cy3)
Kurzübersicht für PRR5 Antikörper (AA 51-150) (Cy3) (ABIN750346)
Target
Alle PRR5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 51-150
-
Homologie
- Human,Mouse,Rat,Dog,Cow,Pig,Chicken
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human Protor-1
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- PRR5 (Proline Rich 5 (Renal) (PRR5))
-
Andere Bezeichnung
- Protor-1
-
Hintergrund
-
Synonyms: Arhgap8, AU043908, C030017C09Rik, C78947, FLJ20185, FLJ20185k, MGC109513, MGC32512, PP610, Proline rich 5 renal, Proline-rich protein 5, Protein observed with Rictor-1, Protor-1, PROTOR1, PRR5, PRR5_HUMAN, PTOR1, RP1-181C9.3.
Background: Protor-1 plays an important role in regulation of PDGF receptor expression and in modulation of PDGF signaling. It is thought that Protor-1 may act as a tumor suppressor in breast cancer.
-
Gen-ID
- 55615
-
Pathways
- PI3K-Akt Signalweg
Target
-